Ching-Lin Hsieh

Technologies

• One and done: A variant-proof coronavirus vaccine
• Monoclonal antibodies for the conserved feature of the coronavirus spike protein
• Engineered chimeric fusion proteins
• Stabilized coronavirus spike proteins for enhanced vaccine efficacy